株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のゲノミクスおよびプロテオミクス分析装置市場

Global Genomics and Proteomics Analytical Instruments Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 308313
出版日 ページ情報 英文 97 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
世界のゲノミクスおよびプロテオミクス分析装置市場 Global Genomics and Proteomics Analytical Instruments Market 2014-2018
出版日: 2014年07月14日 ページ情報: 英文 97 Pages
概要

世界のゲノミクスおよびプロテオミクス分析装置市場は、2013年から2018年にかけて、7.83%のCAGRで拡大すると予測されています。

当レポートでは、世界のゲノミクスおよびプロテオミクス分析装置市場の現状、今後の成長見通し、技術別および地域別の動向、主要企業のプロファイルなどを提供しています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 技術別の市場区分

  • クロマトグラフィー機器
  • PCR機器
  • 質量分析機器
  • NGS機器

第8章 地理区分

第9章 購入基準

第10章 市場成長因子

第11章 成長因子とその影響

第12章 市場の課題

第13章 成長因子と課題の影響

第14章 市場動向

第15章 動向とその影響

第16章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
    • M&A
  • ベンダー分析
  • その他の有力ベンダー

第17章 主要ベンダーの分析

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories
  • F. Hoffmann La Roche Ltd.
  • Illumina Inc.
  • PerkinElmer
  • Thermo Fisher Scientific Inc.

第18章 関連レポート

目次
Product Code: IRTNTR3793

About Global Genomics and Proteomics Analytical Instruments

Genomics is the study of the gene and its functions and proteomics is the study of the structure and functions of proteomes or sets of proteins by using molecular biology and bioinformatics tools and technology. Genomics involves the mapping of genes and DNA sequencing to understand the structure and functions of genomes. A proteome is a complete set of proteins expressed by a genome at a certain time. Proteomics primarily involves the use of molecular biology, biochemistry, and genetics to analyze proteins produced by genes through the translation process. Proteins are the primary component of all cells and are responsible for the various functional characteristics of cells. A defect in the genome or proteome structure or function could result in disorders. Thus, genomics and proteomics technologies play an important role in research, drug discovery, and disease diagnosis, which require the identification and study of the defective genome or proteins. It requires various instruments, reagents, and software for protein isolation, purification, identification, quantification, and analysis of the genome and proteome. There are several analytical instruments used for genomics and proteomics, but the instruments most widely used are chromatography systems, mass spectrometers, Polymerase Chain Reaction systems, and Next-generation Sequencing systems.

TechNavio's analysts forecast the Global Genomics and Proteomics Analytical Instruments market will grow at a CAGR of 7.83 percent over the period 2013-2018.

Covered in this Report

The Global Genomics and Proteomics Analytical Instruments market can be divided into four segments: Chromatography, Polymerase Chain Reaction, Mass Spectrometry, and Next-generation Sequencing. This report covers the present scenario and the growth prospects of the Global Genomics and Proteomics Analytical Instruments market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of analytical instruments in the above four segments.

TechNavio's report, the Global Genomics and Proteomics Analytical Instruments Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Genomics and Proteomics Analytical Instruments market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.

Other Prominent Vendors

  • Becton Dickinson and Co.
  • Bruker Corp.
  • GE Healthcare
  • Jasco Inc.
  • Jeol Ltd.
  • Luminex Corp.
  • Qiagen NV
  • Rigaku Corp.
  • Shimadzu Corp.
  • Sigma Aldrich Co. LLC
  • Spectrolab Systems
  • Waters Corp.

Key Market Driver

  • Advances in Genomics and Proteomics Technology

For a full, detailed list, view our report.

Key Market Challenge

  • Lack of Knowledge of Genomics and Proteomics

For a full, detailed list, view our report.

Key Market Trend

  • Focus on Drug Discovery and Disease Diagnosis

For a full, detailed list, view our report.

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Technology

  • 07.1. Global Chromatography Instruments Market
    • 07.1.1. Market Size and Forecast
  • 07.2. Global PCR Instruments Market
    • 07.2.1. Market Size and Forecast
  • 07.3. Global Mass Spectrometry Instruments Market
    • 07.3.1. Market Size and Forecast
  • 07.4. Global NGS Instruments Market
    • 07.4.1. Market Size and Forecast

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
    • 16.1.2. Mergers and Acquisitions
  • 16.2. Vendor Analysis 2013
  • 16.3. Other Prominent Vendors

17. Key Vendor Analysis

  • 17.1. Agilent Technologies Inc.
    • 17.1.1. Key Facts
    • 17.1.2. Business Overview
    • 17.1.3. Business Segmentation by Revenue 2013
    • 17.1.4. Business Segmentation by Revenue 2012 and 2013
    • 17.1.5. Sales by Geography
    • 17.1.6. Business Strategy
    • 17.1.7. Key Information
    • 17.1.8. SWOT Analysis
    • 17.1.9. Strengths
    • 17.1.10. Weaknesses
    • 17.1.11. Opportunities
    • 17.1.12. Threats
  • 17.2. Bio-Rad Laboratories
    • 17.2.1. Key Facts
    • 17.2.2. Business Overview
    • 17.2.3. Business Segmentation by Revenue 2012
    • 17.2.4. Business Segmentation by Revenue 2012 and 2011
    • 17.2.5. Geographical Segmentation by Revenue 2012
    • 17.2.6. Business Strategy
    • 17.2.7. Recent Developments
    • 17.2.8. SWOT Analysis
    • 17.2.9. Strengths
    • 17.2.10. Weakness
    • 17.2.11. Opportunities
    • 17.2.12. Threats
  • 17.3. F. Hoffmann La Roche Ltd.
    • 17.3.1. Key Facts
    • 17.3.2. Business Overview
    • 17.3.3. Business Segmentation
    • 17.3.4. Business Segmentation by Revenue 2012 and 2013
    • 17.3.5. Sales by Geography
    • 17.3.6. Business Strategy
    • 17.3.7. Key Information
    • 17.3.8. SWOT Analysis
    • 17.3.9. Strengths
    • 17.3.10. Weaknesses
    • 17.3.11. Opportunities
    • 17.3.12. Threats
  • 17.4. Illumina Inc.
    • 17.4.1. Key Facts
    • 17.4.2. Business Overview
    • 17.4.3. Business Segmentation
    • 17.4.4. Sales by Geography
    • 17.4.5. Business Strategy
    • 17.4.6. Key Information
    • 17.4.7. SWOT Analysis
    • 17.4.8. Strengths
    • 17.4.9. Weaknesses
    • 17.4.10. Opportunities
    • 17.4.11. Threats
  • 17.5. PerkinElmer
    • 17.5.1. Key Facts
    • 17.5.2. Business Overview
    • 17.5.3. Business Segmentation by Revenue 2013
    • 17.5.4. Business Segmentation by Revenue 2012 and 2013
    • 17.5.5. Business Strategy
    • 17.5.6. Key Developments
    • 17.5.7. SWOT Analysis
    • 17.5.8. Strengths
    • 17.5.9. Weaknesses
    • 17.5.10. Opportunities
    • 17.5.11. Threats
  • 17.6. Thermo Fisher Scientific Inc.
    • 17.6.1. Key Facts
    • 17.6.2. Business Overview
    • 17.6.3. Business Segmentation by Revenue
    • 17.6.4. Product Segmentation by Revenue
    • 17.6.5. Sales by Geography
    • 17.6.6. Business Strategy
    • 17.6.7. Key Information
    • 17.6.8. SWOT Analysis
    • 17.6.9. Strengths
    • 17.6.10. Weaknesses
    • 17.6.11. Opportunities
    • 17.6.12. Threats

18. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Genomics and Proteomics Analytical Instruments Market 2013-2018 (US$ million)
  • Exhibit 3: Global Genomics and Proteomics Analytical Instruments market by Technology
  • Exhibit 4: Chromatography : Segmentation by Technology
  • Exhibit 5: Polymerase Chain Reaction: Segmentation by Technology
  • Exhibit 6: Mass Spectrometry : Segmentation by Technology
  • Exhibit 7: Global Genomics and Proteomics Analytical Instruments Market: Segmentation by Technology 2013
  • Exhibit 8: Global Chromatography Instruments Market 2013-2018 (US$ million)
  • Exhibit 9: Global PCR Instruments Market 2013-2018 (US$ million)
  • Exhibit 10: Global Mass Spectrometry Instruments Market 2013-2018 (US$ million)
  • Exhibit 11: Global NGS Instruments Market 2013-2018 (US$ million)
  • Exhibit 12: Global Genomics and Proteomics Analytical Instruments Market: Segmentation by Geography 2013
  • Exhibit 13: Agilent Technologies Inc.: Business Segmentation by Revenue 2013
  • Exhibit 14: Agilent Technologies Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 15: Agilent Technologies Inc.: Sales by Geography 2013
  • Exhibit 16: Bio-Rad Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 17: Bio-Rad Laboratories: Business Segmentation by Revenue 2012 and 2011 (US$ million)
  • Exhibit 18: Bio-Rad Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 19: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
  • Exhibit 20: F. Hoffmann-La Roche Ltd: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 21: F. Hoffmann-La Roche Ltd: Sales by Geography 2013 (Pharmaceuticals Division)
  • Exhibit 22: F. Hoffmann-La Roche Ltd: Sales by Geography 2013 (Diagnostics Division)
  • Exhibit 23: Illumina Inc.: Business Segmentation 2013
  • Exhibit 24: Illumina Inc.: Sales by Geography 2013
  • Exhibit 25: PerkinElmer: Business Segmentation by Revenue 2013
  • Exhibit 26: PerkinElmer: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 27: Thermo Fisher Scientific Inc.: Business Segmentation by Revenue 2013
  • Exhibit 28: Thermo Fisher Scientific Inc.: Product Segmentation by Revenue 2013
  • Exhibit 29: Thermo Fisher Scientific Inc.: Sales by Geography 2013
Back to Top